BSECompany Update4d ago · 4 Nov 2026, 08:43 pm

Intimation of Merger of Wholly owned subsidiary i.e KHPL with its holding company i.e Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Ltd · 543308

✦ AI SummaryM&A

Krishna Institute of Medical Sciences Ltd has announced the merger of its wholly-owned subsidiary, KIMS Hospitals Private Limited, with the company under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

Attachments (1)

📄

acfde688-b005-4662-b910-6eefdbbd0260.pdf

pdf

Download →
View document text
04th November, 2026 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Plot Dalal Street, No.C/1, 'G' Block Bandra - Kurla Mumbai - 400 001. Complex Scrip Code - 543308 Mumbai - 400 051. ISIN: INE967H01025 Symbol - KIMS ISIN: INE967H01025 Dear Sir/ Madam Sub: Intimation of Merger of wholly-owned subsidiary KIMS Hospitals Private Limited (Transferor Company) with its Holding Company i.e. Krishna Institute of Medical Sciences Limited (Transferee Company) under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Pursuant to provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015,and on the recommendation made by the Audit committee, the Board of Directors of the Krishna Institute of Medical Sciences Limited (the Company) at their meeting held today i.e. 04th November, 2026, has approved the scheme of amalgamation between its wholly-owned subsidiary i.e KIMS Hospitals Private Limited (Transferor Company) with its Holding Company i.e. Krishna Institute of Medical Sciences Limited (Transferee Company) in accordance with the provisions of the Companies Act, 2013 and other applicable laws. The requisite disclosure as per SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, is enclosed as Annexure-A to this letter. Kindly take the above on your record. The same is also uploaded on the Company’s website at: https://www.kimshospitals.com/investors/ > Disclosures under Regulation 62 of the SEBI (LODR) Regulations, 2015 > Intimations filed by the Company > Intimations under Regulation 30. Thanking You, Yours truly For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary and Compliance Officer ANNEXURE – A 1. Name of the entity(ies) KIMS HOSPITALS PRIVATE LIMITED (TRANSFEROR forming part of the COMPANY):- Transferor Company is a wholly-owned subsidiary of Krishna amalgamation/merger, Institute of Medical Sciences Limited. The paid up Capital of the Company is details in brief such as, 6,59,99,999 Equity Shares of Rs. 10/- each amounting to Rs. 65,99,99,990/- size, turnover etc.; KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED (TRANSFEREE COMPANY):- Transferee Company is a holding Company of KIMS Hospitals Private Limited. The paid up Capital of the Company is 42,00,06,484 Equity Shares of Rs. 2/- each amounting to Rs. 84,00,12,968/-. (Rs. in millions) Name of Company Turnover as PAT as on on 31.03.2026 31.03.2026 KIMS Hospitals Private Limited Nil (5) Krishna Institute Of Medical Sciences 17,015 2,607 Limited 2. Whether the transaction Y es, would fall within related party transactions? If However, pursuant to Regulation 23(5)(b) of the SEBI (Listing Obligations yes, whether the same is and Disclosure Requirements) Regulations, 2015, this related party transaction done at “arm’s length entered into between a holding Company and its wholly-owned subsidiary is exempted. 3. Area of business of the The Transferor and Transferee Companies are engaged in Healthcare Activities entity(ies); 4. Rationale for • Simplification of the group corporate structure and elimination of amalgamation/ merger; multiple legal entities. • Achieving operational and administrative efficiencies by pooling resources and management functions. • Optimizing utilization of assets, reduction in statutory compliances, and cost savings. • Strengthening the consolidated financial position and enhancing shareholder value. • Enabling focused management and unified decision-making. 5. In case of cash The Transferor Company is the wholly owned subsidiary of Transferee consideration – amount company and hence there will be no cash consideration or issue of new or otherwise share shares involved under the scheme of Amalgamation/merger. exchange ratio; 6. Brief details of change in Not applicable. shareholding pattern (if any) of listed entity. The shareholding pattern of the Transferee Company remains unchanged.